In this study, 18-week-old AD transgenic mice carrying NSE-controlled APPswe, C57BL/6-Tg (NSE-hAPPsw) Korl were selected due to their rapid and robust amyloid plaque development at that early age [21]. The gene discussed is ENO2; the disease is Alzheimer disease.